Skip to main content

Buddy Creech

Remdesivir helps reduce COVID-19 recovery time: study

Jun. 4, 2020—The investigational antiviral drug remdesivir can shorten the time to recovery in adults hospitalized with COVID-19, according to preliminary results of a clinical trial published last month in The New England Journal of Medicine.

Read more


Buddy Creech, BS’95, MPH’06: Leading COVID-19 treatment trials

May. 15, 2020—Buddy Creech, director, Vanderbilt Vaccine Research Program, is helping lead some of the NIH-funded treatment trials of COVID-19 in hospitalized patients at Vanderbilt University Medical Center.

Read more


Team seeks to identify immune response to influenza

Nov. 1, 2018—Vanderbilt researchers led by Buddy Creech are searching for the key to lasting protection against influenza by examining naturally protecting cells found in bone marrow.

Read more


Volunteers sought for bird flu vaccine trial

Mar. 15, 2018—Vanderbilt University Medical Center is recruiting volunteers to participate in a national study of an investigational vaccine against the H7N9 influenza virus, also known as “bird flu.”

Read more


Vanderbilt leads international effort to develop universal flu vaccine

Oct. 26, 2017—Researchers at Vanderbilt University Medical Center are leading an international effort to develop a universal influenza vaccine that would protect everyone against all strains of the flu anywhere in the world.

Read more


New approach for staph-related skin abscesses explored

Jul. 13, 2017—New multicenter research that includes Vanderbilt University Medical Center (VUMC) investigators, could change treatment approaches to simple skin abscesses, infections often caused by Staphylococcus aureus (staph) bacteria.

Read more


Study tests shorter antibiotic course in children

Dec. 1, 2016—Researchers at Vanderbilt University Medical Center (VUMC) are leading a multicenter clinical trial to evaluate whether a shorter course of antibiotics — five days instead of 10 — is effective at treating community-acquired pneumonia (CAP) in children who show improvement after the first few days of taking antibiotics.

Read more


NIH launches website for StoryCorps project

Jul. 28, 2016—The National Institutes of Health (NIH) is launching its Voices of the NIH Community website, which features a collection of StoryCorps audio recordings from patients, families, researchers, doctors, nurses, staff and volunteers in both the NIH and Vanderbilt University Medical Center (VUMC) communities.

Read more


Creech to direct Vanderbilt Vaccine Research Program

Oct. 8, 2015—Buddy Creech, M.D., MPH, associate professor of Pediatrics, has been named director of the Vanderbilt Vaccine Research Program (VVRP) in the Division of Pediatric Infectious Diseases.

Read more


Faculty Senate introduces leaders; newsletter to launch in October

Sep. 16, 2015—The Faculty Senate, the representative and deliberative body of the Vanderbilt faculties, introduces its leadership for 2015-16.

Read more


Faculty Senate meeting minutes for March 2015 available online

May. 1, 2015—Minutes from the Vanderbilt Faculty Senate’s March 12 meeting are now available online on the Faculty Senate website.

Read more


Staph ‘gangs’ share nutrients during infection: study

Oct. 16, 2014—Antibiotic-resistant bacteria can share resources to cause chronic infections, Vanderbilt investigators have discovered. The findings shed light on a long-standing question in infectious diseases and may inform new treatment strategies.

Read more


VIEW MORE EVENTS >